Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nolan

Showing results (321-330 of 381) with videos related to

Pageof 39
Sort By:
Breast Cancer Research and Treatment|April 27, 2016
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancerAndrew R Green, D Soria, D G Powe, et al.
AIDS (London, England)|July 15, 1997
Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d'IvoireY D Mukadi, S Z Wiktor, I M Coulibaly, et al.
Npj Imaging|April 11, 2025
Three-dimensional fiber orientation mapping of ex vivo human brain at micrometer resolutionChao J Liu, William Ammon, Robert J Jones, et al.
British Journal of Cancer|March 29, 2018
Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypesChitra Joseph, Olivia Macnamara, Madeleine Craze, et al.
Breast Cancer Research and Treatment|July 23, 2016
Erratum to: Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancerAndrew R Green, D Soria, D G Powe, et al.
Science (New York, N.Y.)|March 10, 2007
Spin rate of asteroid (54509) 2000 PH5 increasing due to the YORP effectPatrick A Taylor, Jean-Luc Margot, David Vokrouhlicky, et al.
British Journal of Cancer|February 18, 2015
Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy responseM M Al-Kaabi, A T Alshareeda, D A Jerjees, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Comparing genetic ancestry and self-described race in african americans born in the United States and in AfricaRona Yaeger, Alexa Avila-Bront, Kazeem Abdul, et al.
Plos Pathogens|July 24, 2023
Metabolic reprogramming and altered cell envelope characteristics in a pentose phosphate pathway mutant increases MRSA resistance to β-lactam antibioticsMerve S Zeden, Laura A Gallagher, Emilio Bueno, et al.
Breast Cancer Research and Treatment|December 15, 2015
Clinical utility of reverse phase protein array for molecular classification of breast cancerOla H Negm, Abir A Muftah, Mohammed A Aleskandarany, et al.
Pageof 39

Showing results (321-330 of 381) with videos related to

Sort By:
Pageof 39
Breast Cancer Research and Treatment|April 27, 2016
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancerAndrew R Green, D Soria, D G Powe, et al.
AIDS (London, England)|July 15, 1997
Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d'IvoireY D Mukadi, S Z Wiktor, I M Coulibaly, et al.
Npj Imaging|April 11, 2025
Three-dimensional fiber orientation mapping of ex vivo human brain at micrometer resolutionChao J Liu, William Ammon, Robert J Jones, et al.
British Journal of Cancer|March 29, 2018
Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypesChitra Joseph, Olivia Macnamara, Madeleine Craze, et al.
Breast Cancer Research and Treatment|July 23, 2016
Erratum to: Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancerAndrew R Green, D Soria, D G Powe, et al.
Science (New York, N.Y.)|March 10, 2007
Spin rate of asteroid (54509) 2000 PH5 increasing due to the YORP effectPatrick A Taylor, Jean-Luc Margot, David Vokrouhlicky, et al.
British Journal of Cancer|February 18, 2015
Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy responseM M Al-Kaabi, A T Alshareeda, D A Jerjees, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Comparing genetic ancestry and self-described race in african americans born in the United States and in AfricaRona Yaeger, Alexa Avila-Bront, Kazeem Abdul, et al.
Plos Pathogens|July 24, 2023
Metabolic reprogramming and altered cell envelope characteristics in a pentose phosphate pathway mutant increases MRSA resistance to β-lactam antibioticsMerve S Zeden, Laura A Gallagher, Emilio Bueno, et al.
Breast Cancer Research and Treatment|December 15, 2015
Clinical utility of reverse phase protein array for molecular classification of breast cancerOla H Negm, Abir A Muftah, Mohammed A Aleskandarany, et al.
Pageof 39